Eterna Therapeutics
ERNA
#10359
Rank
โ‚ฌ6.72 M
Marketcap
0,25ย โ‚ฌ
Share price
-2.33%
Change (1 day)
-94.00%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -68,90ย โ‚ฌ

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -64,98ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -106,61ย โ‚ฌ an increase over its 2021 EPS that were of -704,32ย โ‚ฌ.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-68,90ย โ‚ฌ
2022-106,61ย โ‚ฌ-84.86%
2021-704,32ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,75ย โ‚ฌ-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-0,56ย โ‚ฌ-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-1,71ย โ‚ฌ-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-0,10ย โ‚ฌ-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
1,05ย โ‚ฌ-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
0,44ย โ‚ฌ-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA